EE03351B1 - Meetod lerkanidipiinhüdrokloriidi valmistamiseks - Google Patents

Meetod lerkanidipiinhüdrokloriidi valmistamiseks

Info

Publication number
EE03351B1
EE03351B1 EE9700303A EE9700303A EE03351B1 EE 03351 B1 EE03351 B1 EE 03351B1 EE 9700303 A EE9700303 A EE 9700303A EE 9700303 A EE9700303 A EE 9700303A EE 03351 B1 EE03351 B1 EE 03351B1
Authority
EE
Estonia
Prior art keywords
preparation
lercanidipine hydrochloride
lercanidipine
hydrochloride
Prior art date
Application number
EE9700303A
Other languages
English (en)
Estonian (et)
Inventor
Leonardi Amedeo
Motta Gianni
Original Assignee
Recordati S.A., Chemical And Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati S.A., Chemical And Pharmaceutical Company filed Critical Recordati S.A., Chemical And Pharmaceutical Company
Publication of EE03351B1 publication Critical patent/EE03351B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9700303A 1995-05-12 1996-05-09 Meetod lerkanidipiinhüdrokloriidi valmistamiseks EE03351B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI950957A IT1274480B (it) 1995-05-12 1995-05-12 Procedimento migliorato per la preparazione della lercanidipina cloridrato
PCT/EP1996/002122 WO1996035668A1 (en) 1995-05-12 1996-05-09 A process for the preparation of lercanidipine hydrochloride

Publications (1)

Publication Number Publication Date
EE03351B1 true EE03351B1 (et) 2001-02-15

Family

ID=11371581

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700303A EE03351B1 (et) 1995-05-12 1996-05-09 Meetod lerkanidipiinhüdrokloriidi valmistamiseks

Country Status (37)

Country Link
EP (1) EP0824517B1 (es)
JP (1) JP4038622B2 (es)
KR (1) KR100395441B1 (es)
CN (1) CN1101810C (es)
AR (1) AR002739A1 (es)
AT (1) ATE221050T1 (es)
AU (1) AU694046B2 (es)
BG (1) BG62400B1 (es)
BR (1) BR9608374A (es)
CA (1) CA2217849C (es)
CZ (1) CZ288634B6 (es)
DE (1) DE69622552T2 (es)
DK (1) DK0824517T3 (es)
DZ (1) DZ2032A1 (es)
EA (1) EA000346B1 (es)
EE (1) EE03351B1 (es)
EG (1) EG21755A (es)
ES (1) ES2179942T3 (es)
HU (1) HU226709B1 (es)
IL (1) IL118143A (es)
IN (1) IN188486B (es)
IT (1) IT1274480B (es)
MA (1) MA23858A1 (es)
MX (1) MX9708662A (es)
MY (1) MY113802A (es)
NO (1) NO309423B1 (es)
NZ (1) NZ309059A (es)
PL (1) PL185260B1 (es)
PT (1) PT824517E (es)
RO (1) RO119616B1 (es)
SA (1) SA96170216B1 (es)
SK (1) SK283321B6 (es)
TN (1) TNSN96069A1 (es)
TW (1) TW404940B (es)
UA (1) UA46769C2 (es)
WO (1) WO1996035668A1 (es)
ZA (1) ZA963716B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
AU2003274004A1 (en) * 2002-10-16 2004-05-04 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR100713136B1 (ko) * 2005-05-04 2007-05-02 주식회사 대희화학 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법
WO2006134606A1 (en) * 2005-06-15 2006-12-21 Hetero Drugs Limited A novel process for the preparation of lercanidipine
WO2007031865A2 (en) 2005-09-16 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100811497B1 (ko) * 2005-10-19 2008-03-07 신풍제약주식회사 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법
EP1860102B1 (en) * 2006-05-24 2008-11-26 CF Pharma Ltd. Process for Producing Lercanidipine
KR100808281B1 (ko) * 2006-06-30 2008-03-03 주식회사 하원정밀화학 레르카니디핀 및 그 산부가염의 제조방법
CN102020602B (zh) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102516160B (zh) * 2011-12-16 2014-04-02 华润赛科药业有限责任公司 一种高纯盐酸乐卡地平的合成工艺
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN109956943B (zh) * 2019-04-18 2021-07-20 合肥合源药业有限公司 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
PL323236A1 (en) 1998-03-16
TNSN96069A1 (fr) 2005-03-15
DK0824517T3 (da) 2002-11-18
CZ356797A3 (cs) 1998-04-15
NO975176L (no) 1997-11-11
JPH11504932A (ja) 1999-05-11
ITMI950957A1 (it) 1996-11-12
WO1996035668A1 (en) 1996-11-14
HUP9801913A2 (hu) 1998-12-28
AU694046B2 (en) 1998-07-09
BG102034A (en) 1998-04-30
SK283321B6 (sk) 2003-06-03
UA46769C2 (uk) 2002-06-17
EP0824517A1 (en) 1998-02-25
IL118143A (en) 2001-06-14
CN1184468A (zh) 1998-06-10
AR002739A1 (es) 1998-04-29
TW404940B (en) 2000-09-11
ES2179942T3 (es) 2003-02-01
AU5898596A (en) 1996-11-29
JP4038622B2 (ja) 2008-01-30
DE69622552T2 (de) 2003-01-23
CA2217849A1 (en) 1996-11-14
NO309423B1 (no) 2001-01-29
ITMI950957A0 (it) 1995-05-12
IN188486B (es) 2002-10-05
IL118143A0 (en) 1996-09-12
BG62400B1 (bg) 1999-10-29
KR19990008378A (ko) 1999-01-25
MA23858A1 (fr) 1996-12-31
CZ288634B6 (cs) 2001-08-15
PT824517E (pt) 2002-12-31
ATE221050T1 (de) 2002-08-15
NZ309059A (en) 1998-10-28
KR100395441B1 (ko) 2004-02-05
MX9708662A (es) 1998-08-30
PL185260B1 (pl) 2003-04-30
EA000346B1 (ru) 1999-04-29
EA199700374A1 (ru) 1998-10-29
IT1274480B (it) 1997-07-17
HU226709B1 (en) 2009-07-28
HUP9801913A3 (en) 1999-01-28
SA96170216B1 (ar) 2005-12-21
CA2217849C (en) 2007-09-11
BR9608374A (pt) 1999-08-24
NO975176D0 (no) 1997-11-11
SK151497A3 (en) 1998-05-06
EP0824517B1 (en) 2002-07-24
CN1101810C (zh) 2003-02-19
DZ2032A1 (fr) 2002-07-21
DE69622552D1 (de) 2002-08-29
MY113802A (en) 2002-05-31
ZA963716B (en) 1996-11-20
RO119616B1 (ro) 2005-01-28
EG21755A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
NO973612D0 (no) Nytt farmasöytisk preparat
DK0719788T3 (da) Fremgangsmåde til fremstilling af 1-(2'-deoxy-2',2'-difluor-D-ribofuranosyl)-4-aminopyrimidin-2-on-hydrochlorid
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
TR199600857A2 (tr) Nikotinamidin hazirlanmasi icin islem.
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
NO973610D0 (no) Nytt farmasöytisk preparat
EE03394B1 (et) Ropivakaiinvesinikkloriidmonohüdraadi saamise protsess
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
NO973611D0 (no) Nytt farmasöytisk preparat
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
FI963466A (fi) Menetelmä selluloosakarbamaatin valmistamiseksi
FI974002A (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
FI960790A (fi) Menetelmä fluoreenibisfenolin valmistamiseksi

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231